TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025(Status and Outlook)

Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025(Status and Outlook)

  • Category:Life Sciences
  • Published on : 18 December 2024
  • Pages :113
  • Formats:
  • Report Code:SMR-8024139
OfferClick for best price

Best Price: $2600

Equine Rabies Immunoglobulin ERIG Market Size, Share 2024


Market size in 2024 US$ 425.6 million
Forecast Market size by 2030 US$ 625.4 million
Growth Rate CAGR of 6.6% Number of Pages 113 Pages

The global Equine Rabies Immunoglobulin (ERIG) market size was valued at US$ 425.6 million in 2024 and is projected to reach US$ 625.4 million by 2030, at a CAGR of 6.6%

The United States Equine Rabies Immunoglobulin (ERIG) market size was valued at US$ 85.4 million in 2024 and is projected to reach US$ 128.6 million by 2030, at a CAGR of 7.0%

Purified immunoglobulin derived from equine plasma for rabies post-exposure treatment. Material requires specialized processing and purification protocols. Products undergo strict quality control and safety testing.

Healthcare sector leads with 82% share. Manufacturing precision at 99%. Quality compliance achieved 100%. Production efficiency improved 32%. Applications: hospitals (82%), clinics (12%), emergency care (6%). Process improvements enhanced purity 28%. Asia-Pacific dominates with 45% share. Advanced processing grew 38%. Medical partnerships increased 42%. Quality systems represent 25% of costs. Innovation focuses on purification. Emergency medicine shows 35% growth.

Report Overview

Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.

This report provides a deep insight into the global Equine Rabies Immunoglobulin (ERIG) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Rabies Immunoglobulin (ERIG) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Rabies Immunoglobulin (ERIG) market in any manner.

Global Equine Rabies Immunoglobulin (ERIG) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Serum China

Lanzhou Institute of Biological Products

Wuhan Institute of Biological Products

Premium Serums

Haffkine Bio-Pharmaceutical

Bharat Serums

Market Segmentation (by Type)

1500IU

1000IU

400IU

Other

Market Segmentation (by Application)

Category II Exposure

Category III Exposure

Geographic Segmentation

2025North America (USA, Canada, Mexico)

2025Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

2025Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

2025South America (Brazil, Argentina, Columbia, Rest of South America)

2025The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

2025Industry drivers, restraints, and opportunities covered in the study

2025Neutral perspective on the market performance

2025Recent industry trends and developments

2025Competitive landscape & strategies of key players

2025Potential & niche segments and regions exhibiting promising growth covered

2025Historical, current, and projected market size, in terms of value

2025In-depth analysis of the Equine Rabies Immunoglobulin (ERIG) Market

2025Overview of the regional outlook of the Equine Rabies Immunoglobulin (ERIG) Market:

Key Reasons to Buy this Report:

2025Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

2025This enables you to anticipate market changes to remain ahead of your competitors

2025You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

2025The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

2025Provision of market value (USD Billion) data for each segment and sub-segment

2025Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

2025Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

2025Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

2025Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

2025The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

2025Includes in-depth analysis of the market from various perspectives through Porter

Report Attributes Report Details
Report Title Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025(Status and Outlook)
Market size in 2024 US$ 425.6 million
Forecast Market size by 2030 US$ 625.4 million
Growth Rate CAGR of 6.6%
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 113 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Equine Rabies Immunoglobulin (ERIG)
1.2 Key Market Segments
1.2.1 Equine Rabies Immunoglobulin (ERIG) Segment by Type
1.2.2 Equine Rabies Immunoglobulin (ERIG) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Equine Rabies Immunoglobulin (ERIG) Market Overview
2.1 Global Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Equine Rabies Immunoglobulin (ERIG) Market Competitive Landscape
3.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Manufacturers (2019-2025)
3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2019-2025)
3.3 Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Equine Rabies Immunoglobulin (ERIG) Sales Sites, Area Served, Product Type
3.6 Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
3.6.1 Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
4.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Equine Rabies Immunoglobulin (ERIG) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Equine Rabies Immunoglobulin (ERIG) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2025)
6.3 Global Equine Rabies Immunoglobulin (ERIG) Market Size Market Share by Type (2019-2025)
6.4 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2019-2025)
7 Equine Rabies Immunoglobulin (ERIG) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Rabies Immunoglobulin (ERIG) Market Sales by Application (2019-2025)
7.3 Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD) by Application (2019-2025)
7.4 Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate by Application (2019-2025)
8 Equine Rabies Immunoglobulin (ERIG) Market Segmentation by Region
8.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
8.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region
8.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Rabies Immunoglobulin (ERIG) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Serum China
9.1.1 Serum China Equine Rabies Immunoglobulin (ERIG) Basic Information
9.1.2 Serum China Equine Rabies Immunoglobulin (ERIG) Product Overview
9.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.1.4 Serum China Business Overview
9.1.5 Serum China Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
9.1.6 Serum China Recent Developments
9.2 Lanzhou Institute of Biological Products
9.2.1 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Basic Information
9.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Overview
9.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.2.4 Lanzhou Institute of Biological Products Business Overview
9.2.5 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
9.2.6 Lanzhou Institute of Biological Products Recent Developments
9.3 Wuhan Institute of Biological Products
9.3.1 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Basic Information
9.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Overview
9.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
9.3.5 Wuhan Institute of Biological Products Business Overview
9.3.6 Wuhan Institute of Biological Products Recent Developments
9.4 Premium Serums
9.4.1 Premium Serums Equine Rabies Immunoglobulin (ERIG) Basic Information
9.4.2 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Overview
9.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.4.4 Premium Serums Business Overview
9.4.5 Premium Serums Recent Developments
9.5 Haffkine Bio-Pharmaceutical
9.5.1 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Basic Information
9.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Overview
9.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.5.4 Haffkine Bio-Pharmaceutical Business Overview
9.5.5 Haffkine Bio-Pharmaceutical Recent Developments
9.6 Bharat Serums
9.6.1 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Basic Information
9.6.2 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Overview
9.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Market Performance
9.6.4 Bharat Serums Business Overview
9.6.5 Bharat Serums Recent Developments
10 Equine Rabies Immunoglobulin (ERIG) Market Forecast by Region
10.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast
10.2 Global Equine Rabies Immunoglobulin (ERIG) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country
10.2.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region
10.2.4 South America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Equine Rabies Immunoglobulin (ERIG) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Equine Rabies Immunoglobulin (ERIG) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Type (2025-2030)
11.1.2 Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Equine Rabies Immunoglobulin (ERIG) by Type (2025-2030)
11.2 Global Equine Rabies Immunoglobulin (ERIG) Market Forecast by Application (2025-2030)
11.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) Forecast by Application
11.2.2 Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Rabies Immunoglobulin (ERIG) Market Size Comparison by Region (M USD)
Table 5. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) by Manufacturers (2019-2025)
Table 6. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2022)
Table 10. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (USD/Ton) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Equine Rabies Immunoglobulin (ERIG) Sales Sites and Area Served
Table 12. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Type
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Equine Rabies Immunoglobulin (ERIG)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Rabies Immunoglobulin (ERIG) Market Challenges
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (Kilotons)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type (M USD)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) by Type (2019-2025)
Table 25. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2019-2025)
Table 26. Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD) by Type (2019-2025)
Table 27. Global Equine Rabies Immunoglobulin (ERIG) Market Size Share by Type (2019-2025)
Table 28. Global Equine Rabies Immunoglobulin (ERIG) Price (USD/Ton) by Type (2019-2025)
Table 29. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) by Application
Table 30. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Application
Table 31. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2025) & (Kilotons)
Table 32. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2025)
Table 33. Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2019-2025) & (M USD)
Table 34. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application (2019-2025)
Table 35. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate by Application (2019-2025)
Table 36. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2025) & (Kilotons)
Table 37. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2025)
Table 38. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2025) & (Kilotons)
Table 39. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2025) & (Kilotons)
Table 40. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2025) & (Kilotons)
Table 41. South America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2019-2025) & (Kilotons)
Table 42. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Region (2019-2025) & (Kilotons)
Table 43. Serum China Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 44. Serum China Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 45. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 46. Serum China Business Overview
Table 47. Serum China Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 48. Serum China Recent Developments
Table 49. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 50. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 51. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 52. Lanzhou Institute of Biological Products Business Overview
Table 53. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 54. Lanzhou Institute of Biological Products Recent Developments
Table 55. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 56. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 57. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 58. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) SWOT Analysis
Table 59. Wuhan Institute of Biological Products Business Overview
Table 60. Wuhan Institute of Biological Products Recent Developments
Table 61. Premium Serums Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 62. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 63. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 64. Premium Serums Business Overview
Table 65. Premium Serums Recent Developments
Table 66. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 67. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 68. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 69. Haffkine Bio-Pharmaceutical Business Overview
Table 70. Haffkine Bio-Pharmaceutical Recent Developments
Table 71. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Basic Information
Table 72. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Overview
Table 73. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2025)
Table 74. Bharat Serums Business Overview
Table 75. Bharat Serums Recent Developments
Table 76. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Equine Rabies Immunoglobulin (ERIG) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD), 2019-2030
Figure 5. Global Equine Rabies Immunoglobulin (ERIG) Market Size (M USD) (2019-2030)
Figure 6. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Rabies Immunoglobulin (ERIG) Market Size by Country (M USD)
Figure 11. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2023
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2023
Figure 13. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type
Figure 18. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2019-2025)
Figure 19. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2023
Figure 20. Market Size Share of Equine Rabies Immunoglobulin (ERIG) by Type (2019-2025)
Figure 21. Market Size Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application
Figure 24. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2019-2025)
Figure 25. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2023
Figure 26. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application (2019-2025)
Figure 27. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application in 2023
Figure 28. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate by Application (2019-2025)
Figure 29. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2019-2025)
Figure 30. North America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 31. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 32. U.S. Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 33. Canada Equine Rabies Immunoglobulin (ERIG) Sales (Kilotons) and Growth Rate (2019-2025)
Figure 34. Mexico Equine Rabies Immunoglobulin (ERIG) Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 36. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 37. Germany Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 38. France Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 39. U.K. Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 40. Italy Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 41. Russia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 42. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2023
Figure 44. China Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 45. Japan Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 46. South Korea Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 47. India Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 48. Southeast Asia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 49. South America Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (Kilotons)
Figure 50. South America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2023
Figure 51. Brazil Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 52. Argentina Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 53. Columbia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 54. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 57. UAE Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 58. Egypt Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 59. Nigeria Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 60. South Africa Equine Rabies Immunoglobulin (ERIG) Sales and Growth Rate (2019-2025) & (Kilotons)
Figure 61. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Equine Rabies Immunoglobulin (ERIG) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Type (2025-2030)
Figure 65. Global Equine Rabies Immunoglobulin (ERIG) Sales Forecast by Application (2025-2030)
Figure 66. Global Equine Rabies Immunoglobulin (ERIG) Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount